Antibiotic resistance mechanisms of mutant EF-Tu species in Escherichia coli
Authors:
- Leo A. H. ZeefLZLeo A. H. Zeef
- Jeroen R. MestersJMJeroen R. Mesters
- Kathy BoonKBKathy Boon
- Erik L. H. VorstenboschEVErik L. H. Vorstenbosch
- Leendert BoschLBLeendert Bosch
- Pieter H. AnborghPAPieter H. Anborgh
- Andrea ParmeggianiAPAndrea Parmeggiani
- Rolf HilgenfeldRHRolf Hilgenfeld
- 1 December 1995
- journal article
- review article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 73 (11-12) , 1167-1177
Abstract
Analysis of antibiotic-resistant EF-Tu mutants has revealed a connection between resistance and structural elements that participate in the GTPase switching mechanism. Both random and site-directed mutagenesis methods have yielded sets of purified mutant EF-Tu resistant to kirromycin (kirr) or pulvomycin (pulr). All kirr mutations cluster in the interface of domains 1 and 3 of EF-Tu in its GTP-bound conformation, not in that of EF-Tu∙GDP. Other evidence also suggests that kirromycin binds to the interface of wild-type EF-Tu, thereby jamming the GTPase switch. Various functional studies reveal two subsequent resistance mechanisms. The first hinders kirromycin binding to EF-Tu∙GTP and the second occurs after GTP hydrolysis by rejection of bound kirromycin. All pulr mutations cluster in the three-domain junction interface of EF-Tu∙GTP (which is an open hole in EF-Tu∙GDP) and destabilize a salt-bridge network. Pulvomycin may bind nearby and overlap with tRNA binding. Mutations show that a D99–R230 salt bridge is not essential for the transduction of the GTPase switch signal from domain 1. In vivo and in vitro studies reveal that pulvomycin sensitivity is dominant over resistance. This demands a revision of the current view of the mechanism of pulvomycin inhibition of protein synthesis and may support a translation model with two EF-Tus on the ribosome. Several mutant EF-Tu species display altered behaviour towards aminoacyl-tRNA with interesting effects on translational accuracy. Kirr EF-Tu(A375T) is able to reverse the streptomycin-dependent phenotype of a ribosomal protein S12 mutant strain to streptomycin sensitivity.Key words: kirromycin, pulvomycin, streptomycin, GTPase switch, aminoacyl-tRNA.Keywords
This publication has 39 references indexed in Scilit:
- Mutations to kirromycin resistance occur in the interface of domains I and III of EF‐Tu·GTPFEBS Letters, 1994
- Refined structure of elongation factor EF-Tu from Escherichia coliJournal of Molecular Biology, 1992
- How many EF-Tu molecules participate in aminoacyl-tRNA binding and peptide bond formation in Escherichia coli translation?Journal of Molecular Biology, 1990
- MECHANISM OF ACTION OF KIRROMYCIN-LIKE ANTIBIOTICSAnnual Review of Microbiology, 1985
- Allosteric changes of the guanine nucleotide site of elongation factor EF‐TuFEBS Letters, 1982
- The Antibiotics Kirromycin and Pulvomycin Bind to Different Sites on the Elongation Factor Tu from Esclzerichia coliEuropean Journal of Biochemistry, 1982
- Spectroscopic studies of the nucleotide binding site of elongation factor Tu from Escherichia coli. An approach to characterizing the elementary steps of the elongation cycle of protein biosynthesisBiochemistry, 1981
- Identification of the part of kirromycin structure that acts on elongation factor TuFEBS Letters, 1981
- A Mutant Elongation Factor Tu which Does Not Immobilize the Ribosome upon Binding of KirromycinEuropean Journal of Biochemistry, 1981
- Altered regulation of the guanosine 5'-triphosphatase activity in a kirromycin-resistant elongation factor TuBiochemistry, 1981